Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let’s Clear Up That Case With Some Controls-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let’s Clear Up That Case With Some Controls

Published:2021-03-03 Issue:6 Volume:43 Page:e867-e872
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Remy Amandine,Théorêt Yves,Ansari Marc,Bittencourt Henrique,Ducruet Thierry,Nava Tiago,Pastore Yves,Rezgui Mohamed A.,Krajinovic Maja,Kleiber Niina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference20 articles.

1. Pharmacokinetics of busulfan: correlation with veno‐occlusive disease in patients undergoing bone marrow transplantation;Grochow;Cancer Chemother Pharmacol,1989

2. New insights into the pharmacokinetics of intravenous busulfan in children with sickle cell anemia undergoing bone marrow transplantation;Gaziev;Pediatr Blood Cancer,2015

3. Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring;Gaziev;Blood,2010

4. Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem- cell transplantation in thalassemia pediatric patients;Ansari;Bone Marrow Transplant,2016

5. GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study;Ansari;Oncotarget,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions;Expert Opinion on Drug Metabolism & Toxicology;2023-02-01

2. Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease;Journal of Clinical Medicine;2022-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3